A cancer vaccine made just for you. mRNA is back and it's fighting melanoma - NPR
A cancer vaccine made just for you. mRNA is back and it's fighting melanoma NPR A personalized vaccine for melanoma cut the risk of cancer returning after five years NBC News Moderna and Merck Present 5-Year Data for Intismeran Autogene in Combination With KEYTRUDA (pembrolizumab) in Patients With High-Risk Stage III/IV Melanoma Following Complete Resection at the 2026 ASCO Annual Meeting Yahoo Finance ASCO26: Cancer vaccines and at-home injectable drugs continue to show promise Clinical Trials Arena Adjuvant Intismeran/Pembro Shows Durable Benefit at 5 Years in Melanoma Targeted Oncology
YesNo saves this item as an on-site live signal so search users can understand how it connects to prediction markets and incubation topics.
If later reporting creates a clear deadline, official source, or verifiable outcome, the public event can become a tradable Yes/No question.
This item has a verifiable event angle that can be monitored for a Yes/No prediction market.